Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer.
Zhou Q, Liang J, Yang T, Liu J, Li B, Li Y, Fan Z, Wang W, Chen W, Yuan S, Xu M, Xu Q, Luan Z, Xia Z, Zhou P, Huang Y, Chen L.
Zhou Q, et al. Among authors: liang j.
EMBO Mol Med. 2022 Jan 11;14(1):e14502. doi: 10.15252/emmm.202114502. Epub 2021 Dec 13.
EMBO Mol Med. 2022.
PMID: 34898004
Free PMC article.